| 1. Tate MD, Ong JDH, Dowling JK, McAuley JL, Robertson AB, Latz E, Drummond GR, Cooper MA, Hertzog PJ, Mansell A. (2016) Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition.. Sci Rep, 6 (13): (27912). [PMID:27283237] [10.1021/op500134e] |
| 2. Coll RC, Robertson AA, Chae JJ, Higgins SC, Muñoz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A et al.. (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.. Nat Med, 21 (3): (248-55). [PMID:25686105] [10.1021/op500134e] |
| 3. Coates BM, Staricha KL, Ravindran N, Koch CM, Cheng Y, Davis JM, Shumaker DK, Ridge KM. (2017) Inhibition of the NOD-Like Receptor Protein 3 Inflammasome Is Protective in Juvenile Influenza A Virus Infection.. Front Immunol, 8 (13): (782). [PMID:28740490] [10.1021/op500134e] |
| 4. Hettwer J, Hinterdobler J, Miritsch B, Deutsch MA, Li X, Mauersberger C, Moggio A, Braster Q, Gram H, Robertson AAB et al.. (2021) Interleukin-1β suppression dampens inflammatory leukocyte production and uptake in atherosclerosis.. Cardiovasc Res, 71 (13): (1755-70). [PMID:34718444] [10.1093/cvr/cvab337] |
| 5. Ni B, Pei W, Qu Y, Zhang R, Chu X, Wang Y, Huang X, You H. (2021) MCC950, the NLRP3 Inhibitor, Protects against Cartilage Degradation in a Mouse Model of Osteoarthritis.. Oxid Med Cell Longev, 2021 (13): (4139048). [PMID:34777685] [10.1021/op500134e] |
| 6. Kennedy CR, Goya Grocin A, Kovačič T, Singh R, Ward JA, Shenoy AR, Tate EW. (2021) A Probe for NLRP3 Inflammasome Inhibitor MCC950 Identifies Carbonic Anhydrase 2 as a Novel Target.. ACS Chem Biol, 16 (6): (982-990). [PMID:34003636] [10.1021/op500134e] |
| 7. Corcoran SE, Halai R, Cooper MA. (2021) Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950.. Pharmacol Rev, 73 (3): (968-1000). [PMID:34117094] [10.1021/op500134e] |
| 8. Zeng W, Wu D, Sun Y, Suo Y, Yu Q, Zeng M, Gao Q, Yu B, Jiang X, Wang Y. (2021) The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages.. Sci Rep, 11 (1): (19305). [PMID:34588488] [10.1021/op500134e] |
| 9. Wang S, Yuan YH, Chen NH, Wang HB. (2019) The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.. Int Immunopharmacol, 67 (13): (458-464). [PMID:30594776] [10.1021/op500134e] |
| 10. Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, Chitty JL, Fraser JA, Jennings MP, Robertson AAB et al.. (2019) MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition.. Nat Chem Biol, 15 (6): (556-559). [PMID:31086327] [10.1021/op500134e] |
| 11. Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S, McManus RM, Tejera D et al.. (2019) NLRP3 inflammasome activation drives tau pathology.. Nature, 575 (7784): (669-673). [PMID:31748742] [10.1021/op500134e] |
| 12. Dekker C, Mattes H, Wright M, Boettcher A, Hinniger A, Hughes N, Kapps-Fouthier S, Eder J, Erbel P, Stiefl N et al.. (2021) Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition.. J Mol Biol, 433 (24): (167309). [PMID:34687713] [10.1021/op500134e] |
| 13. Wang Z, Zhang S, Xiao Y, Zhang W, Wu S, Qin T, Yue Y, Qian W, Li L. (2020) NLRP3 Inflammasome and Inflammatory Diseases.. Oxid Med Cell Longev, 2020 (13): (4063562). [PMID:32148650] [10.1021/op500134e] |
| 14. Fenini G, Contassot E, French LE. (2017) Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.. Front Pharmacol, 8 (13): (278). [PMID:28588486] [10.1021/op500134e] |
| 15. De-Wen Bi, Ying-Xin Zhao, Xiong Qiu, Xue-Cong Zhang, Ya-Ling Zhou, Muhammad Aurang Zeb, Wen-Hui Pang, Rui Li, Meng-Ru Wang, Bin Cheng, Jing-Jing Zhang, Xing-Jie Zhang, Xiao-Li Li, Rui-Han Zhang, Wei-Lie Xiao. (2022) Callicarpanes A–L, Twelve New Clerodane Diterpenoids with NLRP3 Inflammasome Inhibitory Activity from Callicarpa integerrima. CHEMISTRY & BIODIVERSITY, 20 (1): (e202200985). [PMID:36433761] [10.1002/cbdv.202200985] |
E2416333
